Aspect Biosystems
The role involves leading the development and optimization of cell‑based analytical methods, such as ddPCR, qPCR, flow cytometry, and ELISAs, to support the characterization of bioprinted tissue therapeutics. The scientist will collaborate cross‑functionally with Process Development, QC, Research & Development, and Manufacturing, ensuring analytical methods meet precision, scalability, and regulatory standards.
Headquarters
Vancouver, British Columbia, Canada
Company Size
51-200 employees
Founded
2013
Aspect Biosystems is a biotechnology company pioneering bioprinted tissue therapeutics. Its full‑stack platform combines proprietary AI‑powered bioprinting, computational design tools, therapeutic cells, and advanced biomaterials to manufacture allogeneic implantable tissues. The company is developing a targeted pipeline focused on metabolic and endocrine diseases and partners with pharma and biotech to translate therapies to the clinic. A multidisciplinary team of scientists, engineers, and entrepreneurs drives its regenerative‑medicine efforts.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Aspect Biosystems.
6% above the average for this role
Analytical Development Scientist
Artiva Biotherapeutics
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Associate Director
Gilead Sciences
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Quality Control Analyst I - Cell Therapy (AM Shift)
Lonza
Molecular Biology Analytical Scientist
Eurofins